Related Experiment Videos
Choriocarcinoma in Ibadan: clinicopathologic studies
Human Pathology
|March 1, 1976
Summary
Host tissue reactions in choriocarcinoma patients showed a mononuclear cellular response in 42% of cases. This immune cell activity did not correlate with patient survival, suggesting other factors like late presentation impact outcomes.
Area of Science:
- Oncology
- Immunology
- Pathology
Background:
- Choriocarcinoma is a rare gestational trophoblastic neoplasm.
- Understanding host immune responses is crucial for predicting cancer outcomes.
- Previous studies on host tissue reactions in choriocarcinoma are limited, especially in specific populations.
Purpose of the Study:
- To investigate the host tissue reaction to choriocarcinoma in Nigerian patients.
- To analyze the composition of the cellular infiltrate around tumor deposits.
- To determine any correlation between the intensity of the host cellular reaction and patient survival.
Main Methods:
- Histopathological examination of tumor samples from 81 Nigerian patients with choriocarcinoma.
- Quantification and characterization of mononuclear cellular infiltrates (lymphocytes, plasma cells, histiocytes, eosinophils).
- Correlation analysis between the intensity of cellular reaction and patient survival data.
Main Results:
- A mononuclear cellular reaction was observed in approximately 42% of the patients.
- The cellular infiltrate predominantly comprised lymphocytes, plasma cells, histiocytes, and eosinophils.
- No significant correlation was found between the intensity of the host cellular reaction and patient survival.
- The syncytiotrophoblast was identified as playing a primary role in vascular invasion.
Conclusions:
- The host's mononuclear cellular reaction to choriocarcinoma does not appear to be a significant prognostic factor for survival.
- Late presentation for medical care and treatment may contribute to poor chemotherapy response in this cohort.
- The syncytiotrophoblast's role in vascular invasion highlights its importance in choriocarcinoma's metastatic potential.